Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2025-12-28 @ 12:24 PM
Study NCT ID:
NCT06748495
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-27
First Post:
2024-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer
Sponsor:
Hunan Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-27
First Submit QC Date:
None
Study First Post Date:
2024-12-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-25
Last Update Post Date:
2025-02-27
Last Update Post Date Type:
ACTUAL